Biotech

All Articles

2 cancer biotechs combine, producing worldwide impact

.OncoC4 is taking AcroImmune-- and also its own internal medical manufacturing capabilities-- under ...

Amgen records first period 3 gain for $400M dermatitis medication

.Amgen has actually discussed (PDF) the 1st period 3 information on its own $400 thousand dermatitis...

Biogen, UCB file phase 3 lupus win after falling short earlier test

.Biogen and UCB's bank on developing in to period 3 astride a failed research study looks to have ac...

Aptadir really hopes brand-new RNA preventions can reverse challenging cancers

.Italian biotech Aptadir Rehabs has introduced along with the assurance that its pipeline of preclin...

Wave surfs DMD effectiveness to regulators' doors, sending out stock up

.Wave Life Sciences has met its goal in a Duchenne muscle dystrophy (DMD) research, positioning it t...

Sanofi tweezes brand-new CSO coming from in-stealth biotech

.After a couple of years in biotech, Mike Quigley, Ph.D., is returning to the pharma fold, occupying...

Achilles splashes tissue therapy plan, braces for unemployments after overlooking 'commercial practicality' objectives

.Achilles Therapeutics has torn up its strategy. The English biotech is actually stopping work on it...

Aligos advertises period 2 MASH gain, slashing liver excess fat around 46%

.Aligos Therapeutics is proclaiming a midstage gain in metabolic-dysfunction associated steatohepati...

Basilea credit ratings $268M BARDA financing for antifungals, anti-biotics

.Basilea Pharmaceutica's job cultivating brand-new antifungals has received a significant increase f...

Capricor offers Europe civil liberties to late-stage DMD treatment for $35M

.Possessing actually scooped up the united state legal rights to Capricor Therapeutics' late-stage D...